ScoreWhy is Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -2.43% and Operating profit at 5.85% over the last 5 years
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.83%
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.43%
- NET SALES(Q) Lowest at CNY 1,173.99 MM
2
With ROE of 39.69%, it has a very attractive valuation with a 2.83 Price to Book Value
- Over the past year, while the stock has generated a return of 43.69%, its profits have risen by 285.1% ; the PEG ratio of the company is 0
- At the current price, the company has a high dividend yield of 2.9
3
Market Beating performance in long term as well as near term
- Along with generating 43.69% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
43.69%
0.86
30.21%
China Shanghai Composite
14.77%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-2.43%
EBIT Growth (5y)
5.85%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.98
Tax Ratio
15.22%
Dividend Payout Ratio
44.22%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.54%
ROE (avg)
15.94%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
2.83
EV to EBIT
28.57
EV to EBITDA
24.23
EV to Capital Employed
5.32
EV to Sales
3.35
PEG Ratio
0.03
Dividend Yield
2.93%
ROCE (Latest)
18.63%
ROE (Latest)
39.69%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
ROCE(HY)
Highest at 46.48%
DEBT-EQUITY RATIO
(HY)
Lowest at -57.52 %
RAW MATERIAL COST(Y)
Fallen by -60.21% (YoY
CASH AND EQV(HY)
Highest at CNY 6,547.58 MM
PRE-TAX PROFIT(Q)
Highest at CNY 1,852.94 MM
NET PROFIT(Q)
Highest at CNY 1,553.38 MM
EPS(Q)
Highest at CNY 2.02
-15What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.83%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.43%
NET SALES(Q)
Lowest at CNY 1,173.99 MM
Here's what is working for Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
Pre-Tax Profit
At CNY 1,852.94 MM has Grown at 203.82%
over average net sales of the previous four periods of CNY 609.88 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 1,553.38 MM has Grown at 180.36%
over average net sales of the previous four periods of CNY 554.06 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Debt-Equity Ratio
Lowest at -57.52 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Pre-Tax Profit
Highest at CNY 1,852.94 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 1,553.38 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 2.02
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Cash and Eqv
Highest at CNY 6,547.58 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -60.21% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
Net Sales
At CNY 1,173.99 MM has Fallen at -28.86%
over average net sales of the previous four periods of CNY 1,650.24 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Inventory Turnover Ratio
Lowest at 1.83% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Net Sales
Lowest at CNY 1,173.99 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Debtors Turnover Ratio
Lowest at 2.43%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
